RCT of an Implementation Science Tool to Integrate HIV testing into Family Planning Services

将艾滋病毒检测纳入计划生育服务的实施科学工具的随机对照试验

基本信息

  • 批准号:
    9342984
  • 负责人:
  • 金额:
    $ 17.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2021-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dr. McClelland has been a highly productive researcher in human immunodeficiency virus (HIV) and sexually transmitted disease (STD) prevention and treatment since 1998. He has published 120 peer-reviewed manuscripts of original research and been Principal Investigator on 13 research grants including 8 major NIH- funded studies. Dr. McClelland leads the University of Washington (UW) Mombasa HIV/STD Research Field Site in Kenya, where he has developed an outstanding research and training infrastructure. His past and present trainees include 18 masters (15 as chair), 10 PhD (5 as chair), and 26 post-doctoral researchers (21 as primary mentor). These trainees have been exceptionally successful in career advancement, publishing, and securing additional funding to support their training and research. More than 75% of Dr. McClelland's mentees have remained in academics or other settings where they focus on patient-oriented research. Dr. McClelland has received two prestigious mentoring awards; the UW School of Public Health Outstanding Mentor Award (2012), and the Department of Medicine Mentor of the Year Award (2015). Career Plan, Institutional Environment, and Institutional Commitment The research and mentoring proposed in this application focus on multidisciplinary implementation science. During the past several years, Dr. McClelland has been expanding his research program in this emerging and important field. As a young HIV researcher in the late 1990s, Dr. McClelland began his career by conducting clinical and epidemiological studies of HIV and STD prevention and treatment in Africa. At that time, the key research questions related primarily to `what' works. Today, with a range of proven prevention and treatment tools available, it is a natural extension to include research that focuses on `how' to implement these interventions to maximize population impact. Dr. McClelland is at an ideal point in his career to expand his leadership of multidisciplinary mentoring teams while gaining new skills and refining his approach through structured courses, independent study, and exploration of new mentoring strategies. The overarching objective of Dr. McClelland's mentorship is to support trainees' progress on the path to full research independence. The UW is an ideal environment for this research and mentoring program, with >1 billion dollars in annual research funding, numerous grants to support young investigators in patient-oriented research, and top-ranked programs in Infectious Diseases, Epidemiology, Global Health, and Implementation Science attracting a large number of superb trainees each year. The UW has a strong commitment to Dr. McClelland and his research and mentoring plan. Research Plan Integration of HIV and family planning (FP) services is an approach that holds considerable promise for improving delivery of HIV treatment and prevention services to women. The United States Government Global Health Initiative Strategy of 2010 emphasized linkage of these services to increase efficiency, lower costs, and improve the health of women in low-resource settings. Testing for HIV is the gateway to care and prevention. Integrating HIV testing into FP clinics could open this essential gateway to far more women. Reviews of the literature support the feasibility of integrating these services, but highlight the need for additional research. In this K24 application, we propose a trial of a systems analysis and improvement approach (SAIA) to optimize rates of HIV testing in women presenting to FP clinics in Mombasa County, Kenya. This work will be conducted in collaboration with the Mombasa County Department of Health (DOH) and Kenya's National AIDS and STI Control Programme (NASCOP), ensuring rapid dissemination of results and facilitating scale up of successful strategies. Our proposal includes three specific aims. We will first conduct a cluster-randomized trial comparing the effect of the SAIA approach versus usual procedures on rates of HIV testing in first-time attendees at 12 intervention versus 12 control FP clinics. Second, to determine whether the SAIA training results in a lasting effect, we will compare HIV testing rates for first-time FP clinic attendees in SAIA intervention versus control facilities after an additional year, during which FP clinics in the intervention arm will be encouraged to continue to use the SAIA tools without further support or training from the study team. Third, we will estimate the incremental cost of applying the SAIA intervention versus standard procedures. Budget impact will be estimated from the payer (DOH) perspective. We envision that each aim will be led by one of Dr. McClelland's mentees. Collaboration and team mentoring with Drs. Sherr (Implementation Science) and Barnabas (Costing/Budget Impact Analysis) will provide the multidisciplinary expertise that is key to the success of this research and mentoring proposal. Integrating HIV and FP services in Mombasa County will result in improved rates of HIV testing, opening the gateway for linkage of women to other HIV prevention and treatment services. Rigorous testing of the SAIA intervention will provide a framework for scale-up in a wide range of settings with a high burden of HIV.
描述(由申请人提供):McClelland博士自1998年以来一直是人类免疫缺陷病毒(HIV)和性传播疾病(STD)预防和治疗方面的高产研究人员。他发表了120篇同行评审的原创研究手稿,并担任13项研究赠款的主要研究者,包括8项主要的NIH资助研究。McClelland博士领导华盛顿大学(UW)肯尼亚蒙巴萨艾滋病毒/性病研究现场,在那里他开发了一个杰出的研究和培训基础设施。他过去和现在的学员包括18名硕士(15名担任主席),10名博士(5名担任主席)和26名博士后研究人员(21名担任主要导师)。这些受训人员在职业发展、出版和获得额外资金以支持他们的培训和研究方面都非常成功。超过75%的McClelland博士的学员仍然在学术或其他环境中,他们专注于以患者为导向的研究。McClelland博士获得了两个著名的指导奖;公共卫生杰出导师奖(2012年)的UW学校,和年度医学导师奖(2015年)的部门。职业规划,制度环境和制度承诺在此申请中提出的研究和指导侧重于多学科的实施科学。在过去的几年里,McClelland博士一直在扩大他在这一新兴和重要领域的研究计划。作为20世纪90年代末的一名年轻的艾滋病毒研究人员,McClelland博士的职业生涯始于在非洲进行艾滋病毒和性病预防和治疗的临床和流行病学研究。当时,关键的研究问题主要涉及“什么”起作用。今天,有了一系列经过验证的预防和治疗工具,自然就可以将重点放在“如何”实施这些干预措施以最大限度地扩大人口影响的研究包括在内。麦克莱兰博士正处于其职业生涯的理想阶段,可以扩大他对多学科指导团队的领导力,同时通过结构化课程、独立学习和探索新的指导策略来获得新技能并改进他的方法。McClelland博士导师的首要目标是支持学员在完全独立研究的道路上取得进步。华盛顿大学是这项研究和指导计划的理想环境,每年有超过10亿美元的研究资金,许多赠款用于支持年轻的研究人员进行以患者为导向的研究,以及传染病,流行病学,全球健康和实施科学方面的顶级计划,每年吸引大量优秀的学员。华盛顿大学对麦克莱兰博士及其研究和指导计划有着坚定的承诺。研究计划艾滋病毒和计划生育服务一体化是一种方法,在改善向妇女提供艾滋病毒治疗和预防服务方面具有相当大的希望。美国政府2010年全球卫生倡议战略强调将这些服务联系起来,以提高效率,降低成本,改善资源匮乏环境中妇女的健康。艾滋病毒检测是获得护理和预防的途径。将艾滋病毒检测纳入计划生育诊所可以为更多的妇女打开这一重要门户。文献综述支持整合这些服务的可行性,但强调需要进行更多的研究。在这个K24应用程序中,我们提出了一个系统分析和改进方法(SAIA)的试验,以优化在肯尼亚蒙巴萨县FP诊所的妇女艾滋病毒检测率。这项工作将与蒙巴萨县卫生部和肯尼亚国家艾滋病和性传播感染控制方案合作进行,确保迅速传播成果,促进推广成功的战略。我们的建议包括三个具体目标。我们将首先进行一项随机分组试验,比较SAIA方法与常规程序对12个干预与12个对照FP诊所首次就诊者HIV检测率的影响。其次,为了确定SAIA培训是否产生持久的效果,我们将在一年后比较SAIA干预与对照机构首次FP诊所就诊者的HIV检测率,在此期间,将鼓励干预组的FP诊所继续使用SAIA工具,而无需研究团队的进一步支持或培训。第三,我们将评估应用SAIA干预与标准程序的增量成本。预算影响将从付款人(DOH)的角度进行估计。我们设想每个目标将由McClelland博士的一名学员领导。Sherr(实施科学)和Barnabas(成本/预算影响分析)将提供多学科的专业知识,这是这项研究和指导提案成功的关键。在蒙巴萨州整合艾滋病毒和计划生育服务将提高艾滋病毒检测率,为妇女获得其他艾滋病毒预防和治疗服务打开大门。对SAIA干预措施的严格测试将为在艾滋病毒高负担的广泛环境中扩大规模提供一个框架。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raymond Scott McClelland其他文献

Raymond Scott McClelland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raymond Scott McClelland', 18)}}的其他基金

University of Washington Vaccine and Treatment Evaluation Unit - DMID 21-0012
华盛顿大学疫苗和治疗评估单位 - DMID 21-0012
  • 批准号:
    10410301
  • 财政年份:
    2021
  • 资助金额:
    $ 17.7万
  • 项目类别:
University of Washington Vaccine and Treatment Evaluation Unit
华盛顿大学疫苗和治疗评估单位
  • 批准号:
    10462171
  • 财政年份:
    2021
  • 资助金额:
    $ 17.7万
  • 项目类别:
University of Washington Vaccine and Treatment Evaluation Unit
华盛顿大学疫苗和治疗评估单位
  • 批准号:
    10467264
  • 财政年份:
    2021
  • 资助金额:
    $ 17.7万
  • 项目类别:
University of Washington Vaccine and Treatment Evaluation Unit -- DMID 20-0034
华盛顿大学疫苗和治疗评估单位 -- DMID 20-0034
  • 批准号:
    10360371
  • 财政年份:
    2021
  • 资助金额:
    $ 17.7万
  • 项目类别:
University of Washington Vaccine and Treatment Evaluation Unit
华盛顿大学疫苗和治疗评估单位
  • 批准号:
    10533733
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
Impact of the vaginal microbiome on Chlamydia trachomatis acquisition
阴道微生物组对沙眼衣原体感染的影响
  • 批准号:
    10541862
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
University of Washington Vaccine and Treatment Evaluation Unit
华盛顿大学疫苗和治疗评估单位
  • 批准号:
    10306378
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
RCT of an Implementation Science Tool to Integrate HIV testing into Family Planning Services
将艾滋病毒检测纳入计划生育服务的实施科学工具的随机对照试验
  • 批准号:
    9761315
  • 财政年份:
    2016
  • 资助金额:
    $ 17.7万
  • 项目类别:
Impact of periconceptual vaginal microbiota on women's risk of preterm birth
围孕期阴道微生物群对女性早产风险的影响
  • 批准号:
    9342979
  • 财政年份:
    2016
  • 资助金额:
    $ 17.7万
  • 项目类别:
Motivation matters! RCT of theory-based, SMS to support TASP in high-risk women
动机很重要!
  • 批准号:
    8807554
  • 财政年份:
    2015
  • 资助金额:
    $ 17.7万
  • 项目类别:

相似海外基金

HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
  • 批准号:
    495195
  • 财政年份:
    2023
  • 资助金额:
    $ 17.7万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10013921
  • 财政年份:
    2020
  • 资助金额:
    $ 17.7万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10181081
  • 财政年份:
    2020
  • 资助金额:
    $ 17.7万
  • 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
  • 批准号:
    10166309
  • 财政年份:
    2020
  • 资助金额:
    $ 17.7万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10597008
  • 财政年份:
    2020
  • 资助金额:
    $ 17.7万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10386931
  • 财政年份:
    2020
  • 资助金额:
    $ 17.7万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9921510
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9753631
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    10265667
  • 财政年份:
    2019
  • 资助金额:
    $ 17.7万
  • 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
  • 批准号:
    364681
  • 财政年份:
    2017
  • 资助金额:
    $ 17.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了